← Back
Healthcare growth

Nova Leap Health hits record revenue, EBITDA in Q2 2026

Nova Leap Health Corp. reported record revenue and EBITDA in Q2 2026, showing a big jump in both income and profit.
By
Three workers in uniforms and blue helmets install pipes against a brick wall.
Foto: Symbolbild | Wikimedia Commons · Symbolbild (Wikimedia Commons: Chris Dobbin) - nicht das Originalfoto der Quelle.
The essentials
  • Nova Leap Health made $9,393,302 in revenue in Q2 2026, up 17.1% from the same quarter in 2025.
  • Adjusted EBITDA in Q2 2026 was $954,836, a 65.2% increase from Q2 2025.
  • Nova Leap generated income from operating activities of $754,667 in Q2 2026, a 115.4% increase from the previous year.

Nova Leap Health Corp. is seeing big financial success in the home care services market. In the second quarter of 2026, the company recorded an impressive 65.2% increase in its EBITDA, with a total of $954,836. This rise is well above the $577,907 reported in the same quarter of 2025. Revenue for the period hit $9,393,302, showing a 17.1% growth compared to the $8,021,072 in revenue for Q2 2025. These figures are a key sign of the company’s strong market performance and financial health.

Strong financial performance across the board

Nova Leap maintained a solid gross profit margin in Q2 2026, with 40.3% of revenue representing gross profit. This is nearly equal to the 40.2% margin from Q2 2025. In terms of income from operating activities, the company reported $754,667 for the quarter, more than doubling the $350,439 it achieved in the same period the previous year. Net income also turned positive, with $649,977 earned in Q2 2026, compared to a net loss of $484,008 in Q2 2025. This shift from loss to profit underlines Nova Leap’s improving operational efficiency and financial resilience.

As of June 30, 2026, Nova Leap had $1,441,635 in cash on hand, with an additional $1,055,595 available from its unused revolving credit facility. The company also held $3,532,747 in principal from demand loans and promissory notes, giving it a debt-to-trailing twelve-month Adjusted EBITDA ratio of 1.36x. These figures reflect a balanced approach to managing liquidity and debt, ensuring that the company remains well-positioned for ongoing growth and stability.

Growth through acquisitions and office expansion

On May 1, 2026, Nova Leap completed the acquisition of a home care services company in Nova Scotia for CAD$3,500,000. The deal involved CAD$3,200,000 in cash at closing and CAD$300,000 in a promissory note to be paid over three years. The cash required for the transaction was covered by a CAD$2,200,000 draw on the company’s acquisition debt facility and an additional CAD$1,000,000 from cash reserves. This strategic move expands Nova Leap’s footprint and enhances its market density in key regions.

During the month of June 2026, Nova Leap opened a new office in Waltham, Massachusetts, aimed at serving the Greater Boston market. This expansion is a core part of the company’s long-term strategy to grow in the U.S. and particularly in Massachusetts. In addition, Nova Leap has access to a credit facility of $3,050,000 for potential acquisitions, reinforcing its capacity to pursue value-accretive opportunities and sustain its growth trajectory.

CEO highlights financial milestones and expansion

Chris Dobbin, President & CEO of Nova Leap, noted that the second quarter was the strongest financial performance in the company’s history. He highlighted a year-over-year revenue increase of 17.1% and a 65.2% jump in Adjusted EBITDA, reaching nearly $1 million for the quarter. Dobbin also pointed out that the company’s operating margin exceeded 10% for the first time, a key milestone indicating improved profitability and operational efficiency.

Dobbin described the strategic initiatives taken during the quarter, including the acquisition of Parkwood Home Care in Nova Scotia, the opening of a new office in Greater Boston, and the hiring of additional staff to support organic growth in Nova Scotia and New Hampshire. The company has also begun investing in new markets like Florida and Texas, where it sees significant long-term potential.

Currently, insider ownership stands at 42.58%, a figure that Dobbin emphasizes as being significant. He explained that management and the board have a direct stake in the value created for shareholders. This alignment of interests, he added, drives the company’s strategy and operations with a focus on growth that turns into stronger earnings and cash flow. These results, Dobbin said, enable Nova Leap to continue expanding and delivering value to investors.

“Q2 was the strongest financial quarter in Nova Leap’s history”
Between the lines

The acquisition of Parkwood Home Care and new office in Massachusetts show Nova Leap is betting on both market density and strategic expansion.

Frequently asked questions

How much did Nova Leap Health's revenue grow in Q2 2026?

Nova Leap Health's revenue grew by 17.1% in Q2 2026 compared to Q2 2025.

What was the adjusted EBITDA for Nova Leap in Q2 2026?

Nova Leap's adjusted EBITDA was $954,836 in Q2 2026, which is a 65.2% increase from the previous year.

How much cash did Nova Leap Health have available as of June 30, 2026?

As of June 30, 2026, Nova Leap Health had $1,441,635 in available cash and access to a revolving credit facility of $1,055,595.

Based on reporting by Financial Post, compiled by the Tradingbird newsroom. Published 07 Aug 2026, 22:02.
Topics: Growth · Health

Related

Down with old blame, up with new facts · Markets ·

Ultra-processed food firms sue governments to block health policies · Markets ·

GE Vernova stock dips despite $176B backlog · Markets ·

LodgeLink to showcase travel platform at Canaccord conference · Markets ·

Birchtech shrinks authorized shares to 50 million · Markets ·